FDA Generic-Drug Leader Steps Down Amid Agency Changes
The head of the U.S. Food and Drug Administration's generic-drug arm will resign Friday after less than a year in the position, citing an upcoming restructuring of the agency that he...To view the full article, register now.
Already a subscriber? Click here to view full article